Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

CGEN Relative to the S&P 500

CGEN Relative to the Sector

% of Net Income Generated in Each Quarter

Seasonal Chart Analysis

Analysis of the Compugen Ltd. (NASD:CGEN) seasonal charts above shows that a Buy Date of November 24 and a Sell Date of February 21 has resulted in a geometric average return of 14.06% above the benchmark rate of the S&P 500 Total Return Index over the past 20 years. This seasonal timeframe has shown positive results compared to the benchmark in 14 of those periods. This is a good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 20 years by an average of 28.82% per year.

The seasonal timeframe correlates Poorly with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its innovative immuno-oncology pipeline consists of four clinical stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902, bapotulimab. The company’s therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.

To download CGEN seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: CGEN